Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study

Inclusion Criteria: * Participant enrolled in a PACE organization during the implementation time period; * PACE organization contractually receiving pharmacy services from CareKinesis during the implementation time period; and, * Participant's prescriber determines that the participant could potentially benefit from deprescribing the antipsychotic. Exclusion Criteria: * A diagnosis of bipolar disorder, schizophrenia, schizo-affective disorder, acute delirium, Tourette's syndrome, tic disorders, autism, intellectual disability, developmental delay, obsessive-compulsive disorder, alcoholism, cocaine abuse, Parkinson's disease psychosis, or major depressive disorder for which the antipsychotic is specifically prescribed as adjunctive treatment; * Participant's prescriber determines that the participant would likely not benefit or could be harmed from deprescribing the antipsychotic; and, * Participant, or healthcare decision-maker on behalf of the participant (e.g., caregiver) refuses to participate in the deprescribing initiative.